Pfizer-backed VitaDAO spins out biotech company

VitaDAO, which funds longevity research, announced the $300,000 financing of a biotechnology company, the DAO’s first such investment

article-image

PowerUp/Shutterstock modified by Blockworks

share

VitaDAO is announcing the launch of Matrix Biosciences, a biotechnology company led by University of Rochester anti-aging researcher Vera Gorbunova. The launch comes with $300,000 in initial financing, with more funding to come in early 2024. 

The company will expand on Gorbunova’s research on the long life spans and cancer resistance of naked mole rats and examine whether a compound found in the rats could improve human lifespan.

Launched in 2021, VitaDAO funds “longevity” research aimed at extending human life. The DAO currently funds 20 projects, primarily focused on potential “moonshot” contributions to longevity science. Todd White, a VitaDAO core contributor, compared the DAO to an endowment fund, because members don’t take a profit from the research and all revenue is sent to the DAO treasury to fund other projects.

The DAO closed a $4 million funding round earlier this year, headlined by an investment from Pfizer Ventures.

VitaDAO invests in “valley of death”-stage ideas where research is still unproven, White said, adding that Pfizer once put significant resources into an early-stage investment team but judged such investments too risky before investing in VitaDAO.

“They realized we were doing what they were trying to do, but we were doing it better and at a fraction of the cost. And so this was kind of this real sort of Web3 awakening for Pfizer,” White said.

Being a community of researchers, VitaDAO has positioned itself within the “decentralized science” movement and a growing interest in DAOs as research funding tools. 

White said the DAO has struggled to ingratiate itself into the university milieu as blockchain technology struggles to rehab its image in the wake of the FTX collapse. But White feels like the niche field of longevity research shares an ethos with crypto.

Both worlds believe “we’re not going to go through this traditional thing. This is stupid. There’s a whole bunch of impediments here,” White said. “We’re retesting all the original assumptions.”


Get the news in your inbox. Explore Blockworks newsletters:

Tags

Decoding crypto and the markets. Daily, with Byron Gilliam.

Upcoming Events

Javits Center North | 445 11th Ave

Tues - Thurs, March 24 - 26, 2026

Blockworks’ Digital Asset Summit (DAS) will feature conversations between the builders, allocators, and legislators who will shape the trajectory of the digital asset ecosystem in the US and abroad.

Old Billingsgate

Mon - Wed, October 13 - 15, 2025

Blockworks’ Digital Asset Summit (DAS) will feature conversations between the builders, allocators, and legislators who will shape the trajectory of the digital asset ecosystem in the US and abroad.

recent research

Unlocked by Template (1).jpg

Research

As AI supercharges surveillance, privacy becomes a prerequisite and the winning stack will combine confidentiality with selective disclosure. Zcash’s Tachyon, composable standards on Ethereum/Solana, and compliance-aware pools aim to make private rails the new norm.

article-image

The startup says it aims to rival Stripe and Worldpay by using stablecoins to speed merchant settlements from days to seconds

by Blockworks /
article-image

“S&P 500” for crypto comes as segment gains “established role in global markets,” S&P exec says

article-image

The S&P Digital Markets 50 Index combines 15 cryptocurrencies with 35 crypto-linked companies, offering investors hybrid exposure

by Blockworks /
article-image

Gnosis is betting that openness — not ownership — will define the future of onchain money

article-image

Crypto’s quest to imbue shareholder protections for tokens

article-image

Grass previously raised a seed and Series A rounds and plans to utilize the token purchase to execute on its roadmap